Effects of bilateral breast reduction on anxiety and depression: results of a prospective randomised trial.

We assessed the effects of bilateral breast reduction on anxiety and depression in women with mammary hypertrophy (macromastia). Seventy-three consecutive women referred for consideration for breast reduction were recruited. They were randomised to have either early operation (within six weeks of initial assessment) or delayed operation (within six months of recruitment). The Hospital Anxiety and Depression Score was given before randomisation and four months later. All 73 patients completed the study. The mean (SD) age was 39 (12) years. The groups were matched for age, smoking, social class, and educational achievement. There were highly significant improvements (p<0.001) in symptoms of anxiety and depression. Reduction mammaplasty significantly improved symptoms of clinical depression in women with macromastia.     

单纯型和复杂型巨乳症的诊断及治疗

目的：探讨单纯型和复杂型巨乳症的临床特点,诊断要点及治疗方法,方法：回顾性分析1990－2000年民治21例巨乳症（37个乳房）,包括单纯型巨乳症16例29个乳房,复杂型巨乳症（巨乳症合并纤维腺瘤病等广范围病变者）5例8个乳房的临床,病理资料,结果：患者平均年龄23岁,21例均行手术治疗,16例单纯巨乳症者施以常规缩乳术,5例复杂型巨乳症中,2例为双乳腺纤维腺瘤病合并巨大型巨乳症,采用皮下腺体切除一期乳房成形术,2例几乎占据全乳的单乳巨纤维腺瘤并巨乳症,1例行皮下肿瘤切除,1例行肿瘤切除乳房成形术;1例双乳腺腺有块样物形成者行选择性腺体大部分切除乳房成形术。经随访至今患者乳房外形满意无肿瘤复发,结论：巨乳症好发于青春发育少女和青年妇女,诊断时应注意区别单纯型巨乳症和复杂型巨也症,术前B超,术中仔细探查及快速病检是必要的,单纯巨乳症常规缩乳术即可,复杂型巨乳症则应区别对待,彻底切除病变,一期乳房成形获得满意疗效,乳腺纤维腺瘤病合并巨乳症者,可采用皮下乳腺切除,真皮及皮下组织蒂一期乳房成形术。     

Breast reduction as an alternative treatment option for early breast cancer in women with macromastia

Macromastia has been considered a relative contraindication to breast conservation therapy because of difficulties with postoperative radiation therapy and cosmesis. This study evaluates the feasibility of the inferior pedicle reduction mammaplasty as a component of breast conservation therapy for patients with early breast cancer. A retrospective review identified 6 patients with macromastia receiving oncologic treatment of breast cancer and simultaneous breast reduction. Mean age was 43.5 +/- 8.7 (mean +/- SD) years, and all breast cancers were stage I or II, averaging 2.3 +/- 1.5 cm in size. All patients underwent a Wise-pattern inferior pedicle breast reduction after cancer extirpation and received postoperative radiation as part of their treatment. They were evaluated for postoperative complications, esthetic outcome of the breasts, and local recurrence. Patients in this series were followed for an average of 30.3 months, with no significant postoperative complications and recurrences. Breast reduction incisions healed primarily and adjuvant radiation was completed without a delay. All patients were pleased with the esthetic result and had improvement of their symptoms related to macromastia. Thus, we believe that breast reduction is a reasonable and safe option for early breast cancer patients with macromastia who desire breast conservation therapy. Our combined oncologic and reconstructive approach may improve the outcome of this group of patients with early breast cancers.     

巨乳症的手术疗效比较

目的探讨不同手术方式对巨乳症的治疗效果. 方法 1993年11月～2003年11月,我科共收治巨乳症患者33例66侧,根据乳腺病变的性质、部位、大小、乳房下垂的程度,选择下述不同的术式:垂直双蒂瓣法6例,无垂直切口的横双蒂瓣法12例,双环形切口乳房缩小术15例. 结果术后外观评价:优良27例53侧,中7例13侧;术后乳房疼痛改善率96.8%(30/31),肩背痛及睡眠明显改善100%(31/31,25/25),乳房下皱襞湿疹、皮炎治愈率100%(15/15),术后着装满意率100%(33/33).结论乳房缩小整形术是治疗巨乳症的首选方法,应根据乳房肥大、下垂的程度选择不同的术式.     

Reduction mammaplasty using superior pedicle in macromastia

SUBJECT: The authors present technical details, complications, morphologic and aesthetic results of 26 breast reduction mammaplasty for macromastia (breast reduction more than 1000 g) showing advantages and reliability of technique. MATERIALS AND METHODS: From January 2000 to December 2001, 223 patients underwent bilateral reduction mammaplasty with superior-based pedicled dermo-glandular flap. In 26 of them the weight of removed mammary tissue was over 1000 g in each breast. These 26 cases were evaluated, and the criteria adopted to analyse the results was morphologic and aesthetic evaluation of patient herself (very good, good, acceptable, unacceptable). RESULTS: Mean follow-up for all patients was 15 months. Twenty-six patients (mean age 33.2 years) underwent an average weight of 1131 g (930/2200 g) removed per breast. The following complications were observed: 1 Nipple Areolar Complex ischemia without necrosis; three infections (abscess); four delayed wound closure. The patient subjective evaluation of result was: "very good" in 19 cases (73%); "good" in 5 cases (19.2%) and "acceptable" in the others two cases (7.8%). No case was evaluated "unacceptable". CONCLUSION: Superior dermoglandular pedicle mammaplasty represent a very good and reliable solution for the treatment of macromastia, giving satisfactory cosmetics results with good nipple viability without necrosis. This technique is actually our first choice in the management of macromastia.     

Therapeutic mammoplasty is an appropriate option in a patient with breast cancer and macromastia

Bilateral reduction mammaplasty in women with breast cancer and macromastia allows appropriate oncological surgical treatment with functional and cosmetic benefits and facilitates postoperative radiation therapy. The surgical approach carried out in three patients with breast cancer and macromastia is discussed.     

The effect of obesity on early outcomes in adolescents undergoing reduction mammaplasty

It is not known whether obesity portends poorer outcomes following reduction mammaplasty in adolescent macromastia patients. We review symptoms in obese and nonobese adolescent macromastia patients and describe early outcomes following reduction mammaplasty. Demographics, operative details, and postoperative follow-up data were collected on 67 patients seen at our institution between 1997 and 2008. Variables were compared using 2-sample t tests or Pearson χ/Fisher exact tests. Mean age at surgery was 17.1 ± 1.6 years. Mean body mass index was 27.9 ± 4.5 kg/m, and 32.8% were obese. Thirty-four patients (50.7%) experienced minor complications; 1 patient experienced a major complication. Of patients with complications, obese patients reported a greater number than nonobese patients (P = 0.013). There were no differences in the type of complication or self-reported satisfaction between obese and nonobese patients 34.4 ± 25.7 weeks after surgery. Our findings suggest that reduction mammaplasty is well-tolerated in obese and nonobese adolescents with macromastia and that obesity is not an absolute contraindication to reduction mammaplasty in adolescents.     

Reduction Mammaplasty in a Developing Country: A Guideline for Plastic Surgeons for Patient Selection

Background  

In Ghana and most developing countries there has been no standardized study of reduction mammaplasty (RM) in patients with symptomatic macromastia (SM), despite its debilitating effects. This study aimed to analyze the physical and psychological effects associated with female patients who underwent reduction mammaplasty and to develop a guideline for plastic surgeons in developing countries to know the most important signs and symptoms to consider in SM patients.     

复合组织下蒂法乳房缩小整形术25例

目的：回顾性总结复合组织下蒂法乳房缩小整形术25例病例资料,探讨复合组织下蒂法乳房缩小整形术手术注意事项及其并发症防治。方法：从2003～2008年5年间,对25例女性乳房肥大患者分别进行手术治疗,方法采用复合组织下蒂法。通过对术中复合组织下蒂的修整及术后乳房外形、乳头乳晕复合体血运、术后瘢痕及乳房感觉等方面观察,分析复合组织下蒂法乳房缩小整形术的术中注意事项及术后并发症的防治策略。结果：25例患者均取得了较好的效果,无乳头乳晕复合体血运障碍发生。结论：复合组织下蒂法乳房缩小整形术是较好的乳房缩小术式,良好的术前设计及术中调整是确保手术成功的关键。     

Effects of Breast Reduction on Pulmonary Function

Macromastia causes several health problems, and reduction surgery alleviates them successfully. The purpose of this study was to investigate whether reduction mammaplasty improves possible impairments on pulmonary functions related to macromastia. Thirty-one patients participated in the study. Pulmonary function tests were performed before and 3 months after surgery with a spirometry. Preoperative and postoperative pulmonary function values were compared using a paired t test. Two patients were found to have mild restriction in preoperative spirometric analysis, and they went to normal range in postoperative analysis. All other patients were assessed as having normal values in both preoperative and postoperative analyses. Preoperative and postoperative forced vital capacity values were 2.72 ± 0.06 and 2.79 ± 0.05 L, respectively. The difference was statistically significant (paired t test, P = 0.014). The other parameter in which breast reduction had statistically significant improvement was forced vital capacity performed/predicted ratio (paired t test, P = 0.041). Additionally, the weight of resected breast tissue correlated significantly with the change of forced vital capacity (Pearson correlation coefficient = 0.379, P = 0.036). Breast reduction surgery improves the pulmonary function parameters that are mainly influenced by restrictive states. This result led us to consider that macromastia causes a relative restriction in chest wall compliance, and reduction of breast weight may enhance chest wall compliance and improve pulmonary function.Key words: Breast reduction, Chest compliance, Pulmonary function, SpirometryMacromastia is commonly associated with physical symptoms, including neck, back, shoulder, and breast pain; painful brassiere strap grooving; intertrigo; poor posture; and difficulty exercising. It is also often associated with psychologic symptoms related to unwanted attention, difficulty finding clothing that fits, and low self-esteem.¹ There are a lot of studies reporting on the salutary effects of reduction mammaplasty on women with macromastia.^2–5 However, outcome measures in assessing the result of the procedure are mostly subjective, and there is a need to produce objective measures for evaluating the efficacy of reduction mammaplasty.During breast reduction operations, several times our anesthesiologists have noted a decrease in peak inspiratory pressure just after mammary tissue resection, and this observation provoked us to perform an analysis about the effect of breast reduction on lung functions.The aim of this study was to answer the question of whether lung function improves after breast reduction. This prospective study was designed to evaluate the effect of breast reduction on lung function in women with macromastia.     

Y-Scar Vertical Mammaplasty for Treatment of Mild Macromastia with Pseudoptosis

Y-scar vertical mammaplasty is a technical modification of vertical scar breast reduction, which avoids superior areolar scarring. It has been previously shown to be particularly useful in young patients with mild macromastia and minimal or no ptosis. This case report presents a new indication for which to apply this technical approach. A 58-year-old patient presented with mild macromastia of mainly the inferior pole and pseudoptosis. Since there was no need to transpose the nipple, a Y-scar vertical mammaplasty was performed, removing tissue from the lower pole and preserving upper-pole fullness. Furthermore, superior areolar scarring was avoided. In conclusion, Y-scar vertical mammaplasty may find its use in other less commonly seen patient profiles such as this presented case of an older patient with slightly enlarged breasts and pseudoptosis.     

修复韧带和保留T4肋间神经的巨乳缩小术

目的 探讨一种能保留T4肋间神经和血管韧带的重塑锥体形乳房的巨乳缩小术.方法 对18例轻、中、重度巨乳者,乳腺组织切除选择在乳房中线上、下极部形成中央蒂,蒂部保留了内外侧深浅韧带、T4肋间神经外侧皮支深浅支.蒂部旋转移位固定,缩小乳房基底,增强韧带张力.二瓣法旋转皮瓣从内到外缩小乳房.保留T4肋间神经走行区真皮层以保护其浅支,旋转固定后起到纤维隔的作用.结果 术后乳头乳晕血供和感觉良好,乳房外形挺拔.随访3个月至2年,平均7个月.随访达1年者,瘢痕已不明显,外观无明显改变,患者满意.结论 修复韧带和保留T4肋间神经的巨乳缩小术设计简单,手术时间缩短,术后乳房外形挺拔稳定.     

Vertical reduction mammaplasty utilizing the superomedial pedicle: is it really for everyone?

Background: Classically, the vertical-style reduction mammaplasty utilizing a superomedial pedicle has been limited to smaller reductions secondary to concerns for poor wound healing and nipple necrosis. Objectives: The authors reviewed a large cohort of patients who underwent a vertical-style superomedial pedicle reduction mammaplasty in an attempt to demonstrate its safety and efficacy in treating symptomatic macromastia. Methods: A retrospective review was performed of 290 patients (558 breasts) who underwent a vertical-style superomedial pedicle reduction mammaplasty. All procedures were conducted by one of 4 plastic surgeons over 6 years (JDR, MAA, DLV, DRA). Results: The average resection weight was 551.7 g (range, 176-1827 g), with 4.6% of resections greater than 1000 g. A majority of patients (55.2%) concomitantly underwent liposuction of the breast. The total complication rate was 22.7%, with superficial dehiscence (8.8%) and hypertrophic scarring (8.8%) comprising the majority. Nipple sensory changes occurred in 1.6% of breasts, with no episodes of nipple necrosis. The revision rate was 2.2%. Patients with complications had significantly higher resection volumes and nipple-to-fold distances (P = .014 and .010, respectively). Conclusions: The vertical-style superomedial pedicle reduction mammaplasty is safe and effective for a wide range of symptomatic macromastia. The nipple-areola complex can be safely transposed, even in patients with larger degrees of macromastia, with no episodes of nipple necrosis. The adjunctive use of liposuction should be considered safe. Last, revision rates were low, correlating with a high level of patient satisfaction.     

修复韧带和保留T4肋间神经的巨乳缩小术

目的 探讨一种能保留T4肋间神经和血管韧带的重塑锥体形乳房的巨乳缩小术.方法 对18例轻、中、重度巨乳者,乳腺组织切除选择在乳房中线上、下极部形成中央蒂,蒂部保留了内外侧深浅韧带、T4肋间神经外侧皮支深浅支.蒂部旋转移位固定,缩小乳房基底,增强韧带张力.二瓣法旋转皮瓣从内到外缩小乳房.保留T4肋间神经走行区真皮层以保护其浅支,旋转固定后起到纤维隔的作用.结果 术后乳头乳晕血供和感觉良好,乳房外形挺拔.随访3个月至2年,平均7个月.随访达1年者,瘢痕已不明显,外观无明显改变,患者满意.结论 修复韧带和保留T4肋间神经的巨乳缩小术设计简单,手术时间缩短,术后乳房外形挺拔稳定.     

修复韧带和保留T4肋间神经的巨乳缩小术

目的 探讨一种能保留T4肋间神经和血管韧带的重塑锥体形乳房的巨乳缩小术.方法 对18例轻、中、重度巨乳者,乳腺组织切除选择在乳房中线上、下极部形成中央蒂,蒂部保留了内外侧深浅韧带、T4肋间神经外侧皮支深浅支.蒂部旋转移位固定,缩小乳房基底,增强韧带张力.二瓣法旋转皮瓣从内到外缩小乳房.保留T4肋间神经走行区真皮层以保护其浅支,旋转固定后起到纤维隔的作用.结果 术后乳头乳晕血供和感觉良好,乳房外形挺拔.随访3个月至2年,平均7个月.随访达1年者,瘢痕已不明显,外观无明显改变,患者满意.结论 修复韧带和保留T4肋间神经的巨乳缩小术设计简单,手术时间缩短,术后乳房外形挺拔稳定.     

Surgery of Cosmetic Sequelae After Breast‐Conserving Therapy

Abstract: Although a considerable number of patients have an unfair cosmetic result after breast‐conserving therapy, which correlates with poor psychosocial functioning, surprisingly, really only very few patients undergo surgical correction. The purpose of this article was to report our experience in the surgical treatment of such patients and analyze a special subgroup which required bilateral reduction mammaplasty because of associated symptomatic macromastia and their desire to reduce their breast size. From July 2000 to November 2008, some 23 patients consulted for unsatisfactory cosmetic outcome after breast‐conserving therapy, fourteen of them accepting the surgical treatment proposed and these were operated upon. We used the following techniques: reduction mammaplasty of the contralateral breast for symmetrization (9), bilateral reduction mammaplasty (4), one mammaplasty and augmentation of contra‐lateral breast and one myocutaneous dorsi flap for surgical correction of ipsilateral breast. One patient had serious complications, having partial necrosis of the areola, fat and breast skin necrosis, and needed reoperation for surgical removal of necrotic tissue. Some factors such as obesity and heavy smoking habits could explain this. We were able to evaluate cosmetic outcome in ten patients; late cosmetic outcome was good in seven patients, fair in two and poor in one. Despite the fact that most patients treated by breast‐conserving therapy are satisfied with the fact that they have retained their breasts and minimized an unfair cosmetic outcome, cosmetic evaluation should be introduced as a matter of routine.     

Outcomes in breast reduction surgery

Previous studies have established that patients with macromastia rate their physical and emotional health as substantially poorer than a control population. The aim of the current study was to confirm this discrepancy, and to evaluate the hypothesis that patients with macromastia who undergo bilateral reduction mammaplasty experience a marked improvement of their general health, both physical and emotional, when compared with their preoperative state and age-matched control population. Sixty-nine consecutive patients were enrolled and evaluated preoperatively and 9 months postoperatively. The methods used for patient evaluation were the Short Form SF-36, a health-related quality-of-life questionnaire, and the Brief Symptom Inventory (BSI), a self-reporting instrument used to assess psychological symptoms. Preoperatively, all patients reported physical health poorer than the age-matched control group. At 9 months postoperatively, patients reported substantial improvement in all areas measured by SF-36 and in the variables this study measured with BSI. Postoperative groups reported their health to be similar to the nonpatient control groups. These findings confirm the therapeutic role of bilateral reduction mammaplasty in alleviation of symptoms associated with macromastia and in restoration of normal physical and emotional functioning.     

Macromastia as an etiologic factor in bulimia nervosa: 10-year follow up after treatment with reduction mammaplasty

Patients with psychologic diagnosis such as eating disorders have been automatically disqualified as candidates for plastic surgery. We have previously reported on a cohort of women with bulimia nervosa who presented with symptomatic macromastia. All patients reported that dysfunctional eating habits where in part the result of breast enlargement. Five patients underwent reduction mammaplasty and postoperatively reported relief of physical symptoms and improvement in psychologic well-being. Symptoms of eating disorders were completely eliminated or greatly reduced. The aim of the current study is to evaluate the degree of long-term postoperative satisfaction and recovery from eating disorders. Patients participating in the original study were contacted for long-term follow-up telephone survey. Data regarding current physical symptoms, body dissatisfaction, and eating attitudes measured by the Eating Attitude Test-26 (EAT-26) questionnaire was obtained. A statistical analysis was performed. Data was obtained from 4 patients. All patients maintained consistent recovery from their eating disorder. A statistically significant improvement in eating attitudes was found when comparing pre- and postoperative data obtained from the EAT-26. Comparing body dissatisfaction, pain, and physical symptoms, we found an overall consistent improvement in subjective scoring. Macromastia can produce a distortion of body image and become a secondary cause of eating disorders. Surgical correction of macromastia can correct physical symptoms, improve body image, and lead to permanent amelioration of associated eating disorders. This could, in part, represent a surgical treatment of a psychologic abnormality. Consequently, the presence of an eating disorder should not automatically exclude a woman from surgical consideration.     

Secondary reduction mammaplasty: does initial pedicle design matter?

Reduction mammaplasty is one of the most common plastic surgical procedures performed in the United States. Occasionally patients will require a second reduction to address persistent or recurrent symptomatic macromastia. When the vascular pedicle of a primary breast reduction is unknown, there is uncertainty regarding how best to proceed with a secondary reduction. When the pedicle is known, we include at least the primary pedicle in our operative plan. When unknown, we performed a modified central mound (MCM) reduction technique. The MCM reduction respects the blood supply to the nipple-areolar complex (NAC) by preserving any remaining vascularity that is present within the central mound tissue while also maintaining superior and inferior vascular pedicles. We avoid using a free nipple graft.Thirty patients (60 breasts) underwent repeat breast reductions between 2009 and 2016. Patients were placed into two groups whether their primary vascular pedicle was known or unknown, and then further grouped based on the type of reduction they received. There was no significant difference in the complication rate between patients that underwent an MCM reduction versus those that underwent reduction with other techniques. Most patients maintained breast sensation and none required a free nipple graft.Patients can be offered repeat reduction mammaplasty with the possibility of nipple sensation preservation and a normal-appearing NAC regardless if the primary vascular pedicle is known. If the primary pedicle is unknown, the MCM technique is an excellent option.     

Avoiding free nipple grafting with the inferior pedicle technique

In cases of severe macromastia, the free nipple graft technique has been the traditional alternative to pedicle transposition. Distress over nipple survival in large reduction mammaplasty and long pedicle transposition is largely responsible for this.A retrospective investigation of the records of 142 reduction mammaplasty patients was carried out to determine whether nipple survival or overall complication rates were significantly different in patients undergoing larger (>1500 g per side) as compared with smaller reductions (< 1500 g per side). The 2 patient groups were compared with respect to mild or severe complications. Data were analyzed using Fisher exact test and 2-sample t tests. A P value of < 0.05 was considered statistically significant. No patient in either group had total nipple loss. There were no statistically significant differences in major or minor complications between the 2 groups.In our experience, the inferior pedicle, Wise pattern reduction is a reliable and predictable method of reduction, appropriate for all breast sizes and pedicle lengths.